Evidence map›Paper›PMID 34410522›Full record

ArticleMedical oncology (Northwood, London, England)2021

Suppressed PLIN3 frequently occurs in prostate cancer, promoting docetaxel resistance via intensified autophagy, an event reversed by chloroquine.

Ioannis Lamprou, Avgi Tsolou, Christos Kakouratos, Achilleas G Mitrakas, Erasmia T Xanthopoulou, Katerina Kassela, Ioannis Karakasiliotis, Christos E Zois, Alexandra Giatromanolaki, Michael I Koukourakis

Open access · bronzeAbstract read
In one paragraph

Article in Medical oncology (Northwood, London, England), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.6field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 23 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Ioannis LamprouDepartment of Radiotherapy/Oncology, Democritus University of Thrace, PO BOX 12, 68100, Alexandroupolis, Greece.
Avgi TsolouDepartment of Radiotherapy/Oncology, Democritus University of Thrace, PO BOX 12, 68100, Alexandroupolis, Greece.
Christos KakouratosDepartment of Radiotherapy/Oncology, Democritus University of Thrace, PO BOX 12, 68100, Alexandroupolis, Greece.
Achilleas G MitrakasDepartment of Radiotherapy/Oncology, Democritus University of Thrace, PO BOX 12, 68100, Alexandroupolis, Greece.
Erasmia T XanthopoulouDepartment of Radiotherapy/Oncology, Democritus University of Thrace, PO BOX 12, 68100, Alexandroupolis, Greece.
Katerina KasselaLaboratory of Biology, Democritus University of Thrace, 68100, Alexandroupolis, Greece.
Ioannis KarakasiliotisLaboratory of Biology, Democritus University of Thrace, 68100, Alexandroupolis, Greece.
Christos E ZoisDepartment of Radiotherapy/Oncology, Democritus University of Thrace, PO BOX 12, 68100, Alexandroupolis, Greece.
Alexandra GiatromanolakiDepartment of Pathology, Democritus University of Thrace, 68100, Alexandroupolis, Greece.
Michael I KoukourakisDepartment of Radiotherapy/Oncology, Democritus University of Thrace, PO BOX 12, 68100, Alexandroupolis, Greece. targ@her.forthnet.gr.ORCID http://orcid.org/0000-0002-2324-699X
Democritus University of Thrace · GR

Funding

Hellenic Foundation for Research and Innovation 904
6 · The paper itself

Abstract

Lipid metabolism reprogramming is one of the adaptive events that drive tumor development and survival, and may account for resistance to chemotherapeutic drugs. Perilipins are structural proteins associated with lipophagy and lipid droplet integrity, and their overexpression is associated with tumor aggressiveness. Here, we sought to explore the role of lipid droplet-related protein perilipin-3 (PLIN3) in prostate cancer (PCa) chemotherapy. We investigated the role of PLIN3 suppression in docetaxel cytotoxic activity in PCa cell lines. Additional effects of PLIN3 depletion on autophagy-related proteins and gene expression patterns, apoptotic potential, proliferation rate, and ATP levels were examined. Depletion of PLIN3 resulted in docetaxel resistance, accompanied by enhanced autophagic flux. We further assessed the synergistic effect of autophagy suppression with chloroquine on docetaxel cytotoxicity. Inhibition of autophagy with chloroquine reversed chemoresistance of stably transfected shPLIN3 PCa cell lines, with no effect on the parental ones. The shPLIN3 cell lines also exhibited reduced Caspase-9 related apoptosis initiation. Moreover, we assessed PLIN3 expression in a series of PCa tissue specimens, were complete or partial loss of PLIN3 expression was frequently noted in 70% of the evaluated specimens. Following PLIN3 silencing, PCa cells were characterized by impaired lipophagy and acquired an enhanced autophagic response upon docetaxel-induced cytotoxic stress. Such an adaptation leads to resistance to docetaxel, which could be reversed by the autophagy blocker chloroquine. Given the frequent loss of PLIN3 expression in PCa specimens, we suggest that combination of docetaxel with chloroquine may improve the efficacy of docetaxel treatment in PLIN3-deficient cancer patients.

Indexed as

Drug Resistance, NeoplasmAntineoplastic AgentsAutophagyCell Line, TumorChloroquineDocetaxelGene SilencingHumansMalePerilipin-3Prostatic NeoplasmsAntineoplastic AgentsChloroquineDocetaxelPerilipin-3PLIN3 protein, humanAutophagy (Lipophagy)ChemoresistanceChloroquineDocetaxelPerilipinsProstate cancer

Identifiers

PMID34410522
PMCPMC8374126
OpenAlexW3193453395

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.